Literature DB >> 24899041

Characteristics of acute nongonococcal urethritis in men differ by sexual preference.

Vinita S Rane1, Christopher K Fairley2, Ajith Weerakoon3, Timothy H Read4, Glenda Fehler5, Marcus Y Chen2, Catriona S Bradshaw6.   

Abstract

Nongonococcal urethritis (NGU) is a common clinical syndrome, but no etiological agent is identified in a significant proportion of cases. Whether the spectrum of pathogens differs between heterosexual men (MSW) and men who have sex with men (MSM) is largely unstudied but of considerable clinical relevance. A retrospective review was done using the electronic medical record database of Melbourne Sexual Health Centre, Australia. Cases were first presentations of symptomatic acute NGU with ≥ 5 polymorphonuclear leukocytes (PMNL)/high-powered field (HPF) on urethral Gram stain between January 2006 and December 2011. First-stream urine was tested for Chlamydia trachomatis and Mycoplasma genitalium by PCR. Demographic, laboratory, and behavioral characteristics of cases were examined by univariate and multivariable analyses. Of 1,295 first presentations of acute NGU, 401 (32%; 95% confidence interval [CI] of 29 to 34%) had C. trachomatis and 134 (11%; 95% CI of 9 to 13%) had M. genitalium detected. MSM with acute NGU were less likely to have C. trachomatis (adjusted odds ratio [AOR] = 0.4; 95% CI of 0.3 to 0.6) or M. genitalium (AOR = 0.5; 95% CI of 0.3 to 0.8) and more likely to have idiopathic NGU (AOR = 2.4; 95% CI of 1.8 to 3.3), to report 100% condom use for anal/vaginal sex (AOR = 3.6; 95% CI of 2.7 to 5.0), or to have engaged in sexual activities other than anal/vaginal sex (AOR = 8.0; 95% CI of 3.6 to 17.8). Even when C. trachomatis or M. genitalium was detected, MSM were more likely than MSW to report consistent condom use (OR = 4.7; 95% CI of 2.6 to 8.3). MSM with acute NGU are less likely to have the established bacterial sexually transmitted infections (STIs) and more likely to report protected anal sex or sexual activity other than anal sex prior to symptom onset than MSW. These data suggest that the etiologic spectrum of pathogens differs between MSM and MSW in acute NGU and that relatively low-risk practices are capable of inducing acute NGU.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24899041      PMCID: PMC4136159          DOI: 10.1128/JCM.00899-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Was the Papanicolaou smear responsible for the decline of Trichomonas vaginalis?

Authors:  F J Bowden
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

2.  Urethritis due to Streptococcus pyogenes.

Authors:  T Nebreda; F J Merino; A Campos; A Cia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-10       Impact factor: 3.267

3.  The history of nongonococcal urethritis. Thomas Parran Award Lecture.

Authors:  D Taylor-Robinson
Journal:  Sex Transm Dis       Date:  1996 Jan-Feb       Impact factor: 2.830

4.  Risk factors for urethritis in heterosexual men. The role of fellatio and other sexual practices.

Authors:  M A Schwartz; W E Lafferty; J P Hughes; H H Handsfield
Journal:  Sex Transm Dis       Date:  1997-09       Impact factor: 2.830

5.  Symptoms of non-gonococcal urethritis in heterosexual men: a case control study.

Authors:  P Iser; Tr H Read; S Tabrizi; C Bradshaw; D Lee; L Horvarth; S Garland; I Denham; C K Fairley
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

6.  Sexually transmitted diseases in men who have sex with men. Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention.

Authors:  W E Lafferty; J P Hughes; H H Handsfield
Journal:  Sex Transm Dis       Date:  1997-05       Impact factor: 2.830

7.  Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays.

Authors:  F Kong; Z Ma; G James; S Gordon; G L Gilbert
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis.

Authors:  K Povlsen; E Bjørnelius; P Lidbrink; I Lind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-02       Impact factor: 3.267

Review 9.  Nongonococcal urethritis--a new paradigm.

Authors:  G R Burstein; J M Zenilman
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

10.  Bacterial loads of Ureaplasma urealyticum contribute to development of urethritis in men.

Authors:  Y Shimada; S Ito; K Mizutani; T Sugawara; K Seike; T Tsuchiya; S Yokoi; M Nakano; M Yasuda; T Deguchi
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

View more
  5 in total

Review 1.  Mycoplasma genitalium Infection in Men.

Authors:  Patrick J Horner; David H Martin
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

2.  Patients with cervical Ureaplasma Urealyticum and Chlamydia Trachomatis infection undergoing IVF/ICSI-ET: The need for new paradigm.

Authors:  Qing-Zhen Xie; Wang-Ming Xu; Qian-Rong Qi; Zeng-Li Luo; Lan Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

3.  Cross-sectional study of urethral exposures at last sexual episode associated with non-gonococcal urethritis among STD clinic patients.

Authors:  Laura C Chambers; Jennifer L Morgan; M Sylvan Lowens; Tashina S Robinson; Sarah S Romano; Gina L Leipertz; James P Hughes; Matthew R Golden; Christine M Khosropour; David N Fredricks; Lisa E Manhart
Journal:  Sex Transm Infect       Date:  2018-09-04       Impact factor: 3.519

4.  Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance.

Authors:  Thomas Trevis; Marianne Gossé; Nicola Santarossa; Sepehr Tabrizi; Darren Russell; William John McBride
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

Review 5.  Management of non-gonococcal urethritis.

Authors:  Harald Moi; Karla Blee; Patrick J Horner
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.